AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference on Wednesday, May 13, 2026 at 10:00 a.m. PT. Presenters are Peter Griffith (EVP & CFO) and Jay Bradner (EVP, R&D). The presentation will be webcast and archived for at least 90 days.
Webcast access, timing and links are available on Amgen's Investor Relations Events Calendar on the company website.
Positive
- None.
Negative
- None.
News Market Reaction – AMGN
In the May 8 session, AMGN gained 0.79%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 04 | Manufacturing investment | Positive | -1.8% | Announced additional U.S. biologics manufacturing investment totaling nearly $2B over year. |
| Apr 30 | Earnings correction | Positive | -4.8% | Clarified Q1 2026 revenues, EPS and guidance details following initial earnings release. |
| Apr 30 | Q1 2026 earnings | Positive | -4.8% | Reported Q1 revenue growth, EPS increases, strong margins and full‑year 2026 guidance. |
| Apr 24 | Earnings webcast | Neutral | -1.3% | Announced timing and webcast details for the first quarter 2026 financial results call. |
| Apr 22 | Management change | Neutral | +0.8% | Announced CTO retirement and organizational changes integrating biology, data science and AI. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive operational and earnings updates have coincided with short-term share price declines, while management and scheduling announcements saw relatively mild reactions.
Over the past few weeks, AMGN reported several notable developments. On Apr 30, detailed Q1 2026 earnings showed revenue of $8.6B with EPS growth and full‑year guidance, yet the stock fell about 4.75%. An earlier webcast scheduling release on Apr 24 for those results saw a smaller decline. A major U.S. manufacturing investment update on May 4 also drew a negative reaction, while an organizational update with an executive retirement on Apr 22 coincided with a modest gain. Today’s conference appearance fits into this cadence of frequent investor communications.
Key Terms
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks,
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-bank-of-america-merrill-lynch-global-healthcare-conference-302766201.html
SOURCE Amgen